Quoted Portfolio Companies
Unquoted Portfolio Companies
Sold Companies
 
Friday, March 12, 2010

De Novo Pharmaceuticals logo
 
DE NOVO PHARMACEUTICALS is a computational drug discovery company, spun out from the University of Cambridge, using proprietary computational techniques to design compounds for drug development using information emanating from the genome project.
 
view website 
 
download factsheet (pdf 903kb) 
 
 

Privacy Statement | Sitemap | © 2010 Avlar BioVentures Limited

Avlar BioVentures Limited is authorised and regulated by the Financial Services Authority, who require us to state that investments of this type are only suitable for experienced investors familiar with venture capital and biotechnology companies.